COE Learning Network: Drug Adulterants
The activity will assist the COE team in understanding the types of drug adulterants that exist and how they are monitored within Pennsylvania so that the organization can better care for their clients with substance use disorder, particularly how to treat patients who have been exposed to xylazine.
Agenda:
- Welcome, Introductions, Training Objectives
- Drug Adulterants Overview
- Categories of adulterants
- Definition of adulterants
- List common opioid adulterants
- Fentanyl
- Surveillance for Adulterants
- Current surveillance in PA
- Best practices
- Xylazine Overview
- Xylazine basics
- Xylazine prevalence
- Effects of xylazine
- Signs of use
- Treatment
- Questions
Target Audience
Nurse
Physician
Social Worker
Learning Objectives
• Define drug adulterants
• Identify common opioid adulterants
• Discuss the surveillance for adulterants in Pennsylvania
• Describe the basics of xylazine
• Identify the signs of use, treatment, and physical effects of xylazine
Additional Information
Attachment | Size |
---|---|
Audience Disclosure slides (1.25)_9.pptx | 50.7 KB |
Drug_Adulterants_Agenda_Objectives_Questions_References.docx | 32.87 KB |
COE_LN_Drug_Adulterants_and_Xylazine_v0.pdf | 605.51 KB |
The activity will assist the COE team in understanding the types of drug adulterants that exist and how they are monitored within Pennsylvania so that the organization can better care for their clients with substance use disorder, particularly how to treat patients who have been exposed to xylazine.
Agenda:
- Welcome, Introductions, Training Objectives
- Drug Adulterants Overview
- Categories of adulterants
- Definition of adulterants
- List common opioid adulterants
- Fentanyl
- Surveillance for Adulterants
- Current surveillance in PA
- Best practices
- Xylazine Overview
- Xylazine basics
- Xylazine prevalence
- Effects of xylazine
- Signs of use
- Treatment
- Questions
Katie Holler
Julie Brewer
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and The Jewish Healthcare Foundation. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
As a Jointly Accredited Organization, University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Pittsburgh maintains responsibility for this course. Social workers completing this course receive 1.25 continuing education credits.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 contact hours.
Social Work (ASWB)
The maximum number of hours awarded for this Continuing Social Work Education activity is 1.25 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.25 ASWB
- 1.25 Attendance